GPR75 and metabolic dysfunction-associated steatotic liver disease: In addition, recent research by Hardwick et al. [73] revealed that the 20-HETE/GPR75 axis plays a significant role in the development and progression of metabolic-dysfunction-associated steatosis liver disease (MASLD).